Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
The North East’s largest business organisation has warned that devolution of tax powers to Scotland could harm the North East economy.
A look at the forecast for the Tyne Tees region
The V-pod Pain Distraction Unit uses 3-D technology to help young patients relax, while undergoing treatment.